That may not sound like much. For someone facing a terminal diagnosis, what difference does a few extra months really make, especially if the drugs that enable them cost tens of thousands of dollars, as so many cancer drugs do?
That question misses the point. In medicine, the most important breakthroughs rarely arrive all at once. They are built step by step. First, we gain a few extra months, then a few more, then years, until the disease in question is eradicated.
Read the full article at DC Journal . . .
Big Medical Breakthroughs Start With Small Gains
Sally C. Pipes
A new experimental drug for pancreatic cancer, daraxonrasib, appears to have extended the lives of some patients with advanced disease by several months, according to clinical trial results out last month.
That may not sound like much. For someone facing a terminal diagnosis, what difference does a few extra months really make, especially if the drugs that enable them cost tens of thousands of dollars, as so many cancer drugs do?
That question misses the point. In medicine, the most important breakthroughs rarely arrive all at once. They are built step by step. First, we gain a few extra months, then a few more, then years, until the disease in question is eradicated.
Read the full article at DC Journal . . .
Nothing contained in this blog is to be construed as necessarily reflecting the views of the Pacific Research Institute or as an attempt to thwart or aid the passage of any legislation.